Literature DB >> 17140599

Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations.

Saul R Powell1, Kelvin J A Davies, Andras Divald.   

Abstract

The ubiquitin-proteasome system has been implicated in both cardiac physiology and pathophysiology. Research in this area has been hampered by the lack of a simple, reproducible method to assess 26S-proteasome peptidase activities. The current report demonstrates that one reason for lack of reproducibility is the myriad of ATP concentrations, many of them excessive, which have been used to stimulate peptidase activity. The chymotrypsin-like or caspase-like activities of 26S-proteasome in cardiac tissue isolates were determined using Suc-LLVY-AMC or Z-LLE-AMC, respectively, over a range of ATP concentrations up to 2 mmol/L. The optimal ATP concentration to assess both peptidase activities was found to be in the low micromolar range (from 6 to 100 micromol/L) depending on the cardiac tissue isolate protein (10 to 90 microg protein) contained in the reaction. Increasing ATP beyond the optimal range was inhibitory. In general, chymotrypsin-like and caspase-like activities could be stimulated 2- to 2.5-fold and 1.4- to 1.8-fold, respectively, over basal (ATP, 0 micromol/L), and could be effectively inhibited with lactacystin or Z-Pro-Nle-Asp-CHO, respectively. Based on these observations, an optimized method is presented for ex vivo determination of cardiac 26S-proteasome peptidase activities which was used to confirm inactivation of this complex by myocardial ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140599      PMCID: PMC1820868          DOI: 10.1016/j.yjmcc.2006.10.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  18 in total

Review 1.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

Review 2.  Proteasome inhibitors: from research tools to drug candidates.

Authors:  A F Kisselev; A L Goldberg
Journal:  Chem Biol       Date:  2001-08

3.  Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion.

Authors:  A L Bulteau; K C Lundberg; K M Humphries; H A Sadek; P A Szweda; B Friguet; L I Szweda
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

4.  Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.

Authors:  Kenneth J Rodgers; Roger T Dean
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

5.  ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation.

Authors:  Nadia Benaroudj; Peter Zwickl; Erika Seemüller; Wolfgang Baumeister; Alfred L Goldberg
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

6.  In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes.

Authors:  Xin Dong; Jinbao Liu; Hanqiao Zheng; Joseph W Glasford; Wei Huang; Quan Hai Chen; Niels R Harden; Faqian Li; A Martin Gerdes; Xuejun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-22       Impact factor: 4.733

7.  The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugs.

Authors:  S W French; R J Mayer; F Bardag-Gorce; M Ingelman-Sundberg; H Rouach; E Neve And; H Higashitsuji
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

8.  Comparative resistance of the 20S and 26S proteasome to oxidative stress.

Authors:  T Reinheckel; N Sitte; O Ullrich; U Kuckelkorn; K J Davies; T Grune
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  Zinc improves postischemic recovery of isolated rat hearts through inhibition of oxidative stress.

Authors:  S R Powell; D Hall; L Aiuto; R A Wapnir; S Teichberg; A J Tortolani
Journal:  Am J Physiol       Date:  1994-06

10.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

View more
  43 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation.

Authors:  Todd A Baker; Qing Geng; Jacqueline Romero; Maria M Picken; Richard L Gamelli; Matthias Majetschak
Journal:  Biochem Biophys Res Commun       Date:  2010-09-26       Impact factor: 3.575

3.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

4.  Caveolin and proteasome in tocotrienol mediated myocardial protection.

Authors:  Manika Das; Samarjit Das; Ping Wang; Saul R Powell; Dipak K Das
Journal:  Cell Physiol Biochem       Date:  2008-07-25

Review 5.  Protein quality control and degradation in cardiomyocytes.

Authors:  Xuejun Wang; Huabo Su; Mark J Ranek
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

Review 6.  The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.

Authors:  Saul R Powell; Andras Divald
Journal:  Cardiovasc Res       Date:  2009-09-30       Impact factor: 10.787

7.  Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury.

Authors:  Helena M Linge; Ji Young Lee; Kanta Ochani; Kiyokazu Koga; Nina Kohn; Kaie Ojamaa; Saul R Powell; Edmund J Miller
Journal:  Exp Lung Res       Date:  2015-04-06       Impact factor: 2.459

Review 8.  Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil.

Authors:  Hanming Zhang; Xuejun Wang
Journal:  Future Cardiol       Date:  2015-03

Review 9.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

10.  Clarifying the cardiac proteasome paradox: protein quality control.

Authors:  Christopher C Glembotski
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.